Cardiac Dimensions

Executive Summary

Cardiac Dimensions is a German medical device company developing the Carillon Mitral Contour System, a catheter-based therapy for functional mitral regurgitation (FMR) in heart failure patients. Since its founding in 2001, the company has focused on minimally invasive reshaping of the mitral valve annulus via the coronary sinus to address the underlying cause of FMR, rather than symptom management. The Carillon system has received CE mark and is commercialized in Europe, with ongoing efforts to expand adoption and generate clinical evidence to support FDA approval. The company operates in the competitive cardiovascular space, but its unique approach offers differentiation if outcomes data support efficacy. Given the unmet need in heart failure, Cardiac Dimensions has potential for growth, though near-term catalysts are limited without disclosed trial timelines or partnerships.

Upcoming Catalysts (preview)

• Q3 2026FDA approval decision for Carillon Mitral Contour System60% success
• Q2 2026Release of pivotal clinical trial data for Carillon system70% success
• H2 2026Strategic partnership or distribution agreement in US or Asia45% success